| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $25.42M | $7.66M | $30.04M | $66.09M | $55.03M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $33.99M | $29.91M | $41.93M | $49.61M | $49.82M |
| R&D | – | – | – | – | – |
| SG&A | $5.58M | $6.24M | $4.24M | $6.03M | $9.53M |
| Operating Income | -$8.57M | -$22.25M | -$11.89M | $16.48M | $5.21M |
| Interest Expense | $372.64K | $91.90K | $105.21K | $121.40K | $137.18K |
| Tax Expense | – | $1.65M | $3.54M | $6.59M | $6.30M |
| Net Income | -$43.92M | -$59.90M | -$61.80M | $10.06M | -$924.72K |
| EPS (basic) | -32.9500 | -54.8800 | -5.9200 | 1.0000 | -0.0900 |
| EPS (diluted) | -32.9500 | -54.8800 | – | – | – |
| Shares (diluted) | $1.33M | $1.09M | – | – | – |